Ketamine vs Morphine in Trauma: Does the PACKMaN Study Revolutionize Prehospital Analgesia?
Effective management of acute pain represents a crucial challenge in prehospital emergency care, especially in trauma patients. A recent study published in The Lancet Regional Health - Europe finally offers solid data to guide our clinical practice in choosing between two main pharmacological options: morphine, the long-standing gold standard in prehospital analgesia, and ketamine, an emerging alternative with potentially advantageous pharmacological characteristics.
The PACKMaN study (Paramedic analgesia comparing ketamine and morphine in trauma) represents an important step forward in prehospital analgesia research, being the first double-blind randomized trial directly comparing these two drugs in the management of severe traumatic pain when administered by ALS (Advanced Life Support) paramedics.
The PACKMaN Study: Design and Methodology
The study, conducted in the United Kingdom, involved 449 patients with severe acute pain (≥7/10 on the NRS scale) following trauma, randomized to receive ketamine (n=219) or morphine (n=230). The drugs were administered intravenously by paramedics, with a maximum available dose of 30 mg for ketamine and 20 mg for morphine.
Key trial characteristics:
- Randomized controlled, double-blind, superiority study
- Primary outcome: Sum of Pain Intensity Difference (SPID) at hospital arrival
- Mean dose administered: 18.8 mg of ketamine vs 12.8 mg of morphine
- Mean dose per kg: 0.24 mg/kg of ketamine vs 0.17 mg/kg of morphine
Main Results: Analgesic Efficacy
The most surprising result is that ketamine did not prove superior to morphine in the primary outcome. The SPID was 3.5 (SD 2.8) for ketamine and 3.4 (SD 3.0) for morphine, with an adjusted mean difference of 0.1 (95% CI -0.4 to 0.6, p=0.74).
However, interesting differences emerge in secondary outcomes:
- Patients treated with ketamine were more likely to achieve a
